Please see the links below for press releases and
groundbreaking discoveries from Advanced Cancer Therapeutics
October 11, 2012 - ACT
AWARDED GRANT TO DEVELOP ANTI-CANCER DRUG FOR NOVEL CANCER METABOLISM
TARGET
April
3, 2012 - GRANTED
US PATENT STRENGTHENS ACT ANTI-CANCER PRODUCT PORTFOLIO
January 30, 2012 - ACT
CSO DR. GILLES TAPOLSKY TO PRESENT AT ANNUAL WORLD CANCER METABOLISM
SUMMIT
October 19, 2011 - ACT
CEO TO PRESENT AT MIDAMERICA HEALTHCARE VENTURE FORUM
May 3, 2011 - ADVANCED
CANCER THERAPEUTICS TO ACQUIRE ANTISOMA DRUG
March
8, 2011 - ACT
TO PRESENT PRECLINICAL DATA ON GLYCOLYSIS INHIBITORS AT AACR ANNUAL MEETING
August 10, 2010 - ACT
COLLABORATES WITH BROWN CANCER CENTER RESEARCH SCIENTIST IN CANCER METABOLISM
July 1, 2010 - ACT
RAISES $10 MILLION TO DEVELOP POTENTIALLY LIFESAVING CANCER TREATMENTS
February 23, 2010 - ACT
RECEIVES FINAL $250,000 INVESTMENT FROM COMMONWEALTH SEED CAPITAL
February 3,
2010 - ACT
FUNDS BROWN CANCER CENTER RESEARCH
SCIENTIST TO ACCELERATE I.D. OF
CLINICAL CANDIDATES
June
3, 2009 - ACT
SECURES EXCLUSIVE LICENSE TO ANTI-CANCER THERAPEUTIC
FROM U of L's BROWN CANCER CENTER
September
24, 2008 - JAMES
R. RAMSEY, PH.D. JOINS ADVANCED CANCER THERAPEUTICS BOARD OF DIRECTORS
August
19, 2008 - ACT
APPOINTS GILLES TAPOLSKY, PH.D. TO CHIEF SCIENTIFIC
OFFICER
July
23, 2008 - ACT
LICENSES TECHNOLOGY TO DEVELOP HUMAN PAPILLOMAVIRUS
(HPV) VACCINE
June
25, 2008 - ACT
BUSINESS MODEL AIMS FOR STEADY STREAM OF CANCER
DRUGS
April
14, 2008 - EIGHT
LOUISVILLE COMPANIES AWARDED FUNDING FROM KENTUCKY SCIENCE AND TECHNOLOGY CORP.
March
25, 2008 - ACT
SECURES EXCLUSIVE LICENSE TO SECOND ANTI-CANCER
THERAPEUTIC
March
4, 2008 - ACT
OBTAINS EXCLUSIVE LICENSE TO DUAL MECHANISM ANTI-CANCER
THERAPEUTIC
February 20,
2008 - ROBERT
W. ROUNSAVALL, III JOINS ADVANCED CANCER THERAPEUTICS
BOARD OF DIRECTORS
January
18, 2008 - STARTUP
AIMS TO GET CANCER THERAPIES ON MARKET SOONER
January
18, 2008 - RANDALL
B. RIGGS JOINS ADVANCED CANCER THERAPEUTICS AS PRESIDENT AND CEO
February
8, 2007 - U
OF L SIGNS DEAL TO HELP SPEED CANCER THERAPIES
TO MARKET
|
